Jane Barraclough

1.7k total citations · 1 hit paper
7 papers, 1.3k citations indexed

About

Jane Barraclough is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jane Barraclough has authored 7 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Oncology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jane Barraclough's work include Protein Kinase Regulation and GTPase Signaling (3 papers), Advanced Breast Cancer Therapies (2 papers) and Virus-based gene therapy research (2 papers). Jane Barraclough is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (3 papers), Advanced Breast Cancer Therapies (2 papers) and Virus-based gene therapy research (2 papers). Jane Barraclough collaborates with scholars based in United Kingdom, Australia and New Zealand. Jane Barraclough's co-authors include Robert L. Sutherland, Elizabeth A. Musgrove, C. Elizabeth Caldon, Andrew Stone, Caroline Dive, Arkadiusz Welman, Jian Kang, C. Marcelo Sergio, Michael A. Black and Julia M.W. Gee and has published in prestigious journals such as Nature reviews. Cancer, Nature Protocols and Journal of Cellular Biochemistry.

In The Last Decade

Jane Barraclough

7 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cyclin D as a therapeutic target in cancer

2011 1.1k citations Elizabeth A. Musgrove, C. Elizabeth Caldon et al. Nature reviews. Cancer profile →

Peers

Countries citing papers authored by Jane Barraclough

Since Specialization

Citations

This map shows the geographic impact of Jane Barraclough's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane Barraclough with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane Barraclough more than expected).

Fields of papers citing papers by Jane Barraclough

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jane Barraclough. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane Barraclough. The network helps show where Jane Barraclough may publish in the future.

Co-authorship network of co-authors of Jane Barraclough

This figure shows the co-authorship network connecting the top 25 collaborators of Jane Barraclough. A scholar is included among the top collaborators of Jane Barraclough based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jane Barraclough. Jane Barraclough is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

#	Work	Indexed citations
1	Cyclin E2 Overexpression Is Associated with Endocrine Resistance but not Insensitivity to CDK2 Inhibition in Human Breast Cancer Cells 2012 ·Molecular Cancer Therapeutics ·C. Elizabeth Caldon, C. Marcelo Sergio, Jian Kang, Anita Muthukaruppan, (unknown), Andrew Stone, Jane Barraclough, (unknown), Michael A. Black, Lance D. Miller, Julia M.W. Gee, (unknown), Robert L. Sutherland, Cristin G. Print, Elizabeth A. Musgrove	125
2	Cyclin D as a therapeutic target in cancer breakdown → 2011 ·Nature reviews. Cancer ·Elizabeth A. Musgrove, C. Elizabeth Caldon, Jane Barraclough, Andrew Stone, Robert L. Sutherland	1087
3	Increases in c-Yes Expression Level and Activity Promote Motility But Not Proliferation of Human Colorectal Carcinoma Cells 2007 ·Neoplasia ·Jane Barraclough, Cassandra L. Hodgkinson, Alison Hogg, Caroline Dive, Arkadiusz Welman	28
4	Difluoro analogue of UCS15A triggers activation of exogenously expressed c-Src in HCT 116 human colorectal carcinoma cells 2007 ·Journal of Enzyme Inhibition and Medicinal Chemistry ·Noor Atatreh, Jane Barraclough, Arkadiusz Welman, Christopher Cawthorne, Richard A. Bryce, Caroline Dive, Sally Freeman	3
5	Generation of cells expressing improved doxycycline-regulated reverse transcriptional transactivator rtTA2S-M2 2006 ·Nature Protocols ·Arkadiusz Welman, Jane Barraclough, Caroline Dive	24
6	Increases in c-Src Expression Level and Activity Do Not Promote the Growth of Human Colorectal Carcinoma Cells In Vitro and In Vivo 2006 ·Neoplasia ·Arkadiusz Welman, (unknown), (unknown), Jane Barraclough, Sarah Danson, Stephen Murray, (unknown), Terry D. Allen, Caroline Dive	21
7	Construction and characterization of multiple human colon cancer cell lines for inducibly regulated gene expression 2005 ·Journal of Cellular Biochemistry ·Arkadiusz Welman, Christopher Cawthorne, Jane Barraclough, Nigel Smith, Gareth Griffiths, Rachel Cowen, Judith C. Williams, Ian J. Stratford, Caroline Dive	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact